abstract |
The present invention provides a porphyrinone-derived compound that acts as an EWS-FLI1 transcription factor inhibitor. Pharmaceutical compositions of such porphyrin derivatives, methods for their synthesis, methods of treatment using the same, and assays for identifying inhibitors of EWS-FLI1 oncoprotein are also provided. |